These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30144449)

  • 21. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.
    Koo JH; Cho JY
    Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.
    Klemann CJHM; Xicoy H; Poelmans G; Bloem BR; Martens GJM; Visser JE
    Mol Neurobiol; 2018 Jul; 55(7):5639-5657. PubMed ID: 29019056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.
    Singh K; Singh S; Singhal NK; Sharma A; Parmar D; Singh MP
    Chem Biol Interact; 2010 Apr; 185(2):81-93. PubMed ID: 20230807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MPTP as a mitochondrial neurotoxic model of Parkinson's disease.
    Przedborski S; Tieu K; Perier C; Vila M
    J Bioenerg Biomembr; 2004 Aug; 36(4):375-9. PubMed ID: 15377875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six weeks of voluntary exercise don't protect C57BL/6 mice against neurotoxicity of MPTP and MPP(+).
    Aguiar AS; Tristão FS; Amar M; Chevarin C; Glaser V; de Paula Martins R; Moreira EL; Mongeau R; Lanfumey L; Raisman-Vozari R; Latini A; Prediger RD
    Neurotox Res; 2014 Feb; 25(2):147-52. PubMed ID: 23873578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1.
    Rao SP; Sharma N; Kalivendi SV
    Biochim Biophys Acta Bioenerg; 2020 Mar; 1861(3):148157. PubMed ID: 31987812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
    Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
    Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Jia Y; Li J; Wang Y; Ma Y; Chen L; Zhang H; Xue M; Liang H
    J Agric Food Chem; 2024 Mar; 72(11):5734-5745. PubMed ID: 38453725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models.
    Chattopadhyay M; Chowdhury AR; Feng T; Assenmacher CA; Radaelli E; Guengerich FP; Avadhani NG
    J Biol Chem; 2019 Jun; 294(26):10336-10348. PubMed ID: 31113867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade.
    Kuo HC; Lu CC; Shen CH; Tung SY; Hsieh MC; Lee KC; Lee LY; Chen CC; Teng CC; Huang WS; Chen TC; Lee KF
    J Transl Med; 2016 Mar; 14():78. PubMed ID: 26988860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.